<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 26-month-old male presented with <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> and <z:e sem="disease" ids="C0221260" disease_type="Disease or Syndrome" abbrv="">dystrophic nail</z:e> lesions mimicking <z:e sem="disease" ids="C0040261" disease_type="Disease or Syndrome" abbrv="">onychomycosis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>There was no skin finding </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with <z:chebi fb="3" ids="50113">androgen</z:chebi> and <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> was started due to unavailability of a matched-related hematopoietic stem cell donor </plain></SENT>
<SENT sid="3" pm="."><plain>After 30 months, transfusion support was required </plain></SENT>
<SENT sid="4" pm="."><plain>TINF2 mutation was identified at the age of five and <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita (DC) was confirmed </plain></SENT>
<SENT sid="5" pm="."><plain>TIN2 mutation analysis must be carried out in patients younger than 10 years presenting with <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> even if characteristic physical anomalies of DC is missing </plain></SENT>
<SENT sid="6" pm="."><plain>Genetic confirmation of DC prevents ineffective immunotherapy with misdiagnosis of acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>